Psoriasis in the US Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use

2015/07/27 by Junko Takeshita, Joel M. Gelfand, Penxiang Li +5 · 149 citations
Economics, Econometrics and Finance · Immunology and Microbiology · Medicine · #Confidence interval #Dermatology #Environmental health #Epidemiology #Health Systems, Economic Evaluations, Quality of Life #Internal medicine #Medicine #Odds ratio #Plaque psoriasis #Population #Pregnancy and Medication Impact #Psoriasis #Psoriasis: Treatment and Pathogenesis

paper · pdf · doi:10.1038/jid.2015.296

published in Journal of Investigative Dermatology 135(12), 2955-2963 (Elsevier BV)

openalex publication_date 2015/07/27 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/06

Citations

• Assessing Validity of ICD‐9‐CM and ICD‐10 Administrative Data in Recording Clinical Conditions in a Unique Dually Coded Database
• Psoriatic arthritis: epidemiology, clinical features, course, and outcome

Cited by

• Racial Differences in Perceptions of Psoriasis Therapies: Implications for Racial Disparities in Psoriasis Treatment
• Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population. [europepmc]
• The Patient's Guide to Psoriasis Treatment. Part 3: Biologic Injectables. [europepmc]
• The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases. [europepmc]
• Oral Chinese herbal medicine for psoriasis vulgaris: protocol for a randomised, double-blind, double-dummy, multicentre clinical trial. [europepmc]
• The Importance of Sex Stratification in Autoimmune Disease Biomarker Research: A Systematic Review. [europepmc]
• Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan. [europepmc]
• Racial Differences in Perceptions of Psoriasis Therapies: Implications for Racial Disparities in Psoriasis Treatment. [europepmc]
• A retrospective cohort study to evaluate the development of comorbidities, including psychiatric comorbidities, among a pediatric psoriasis population. [europepmc]
• Dendrimer entrapped microsponge gel of dithranol for effective topical treatment. [europepmc]
• Prescribing Patterns Associated With Biologic Therapies for Psoriasis from a United States Medical Records Database [europepmc]
• Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis. [europepmc]
• Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis. [europepmc]
• Effect of Very-Low-Calorie Ketogenic Diet on Psoriasis Patients: A Nuclear Magnetic Resonance-Based Metabolomic Study. [europepmc]
• Signs of chronic itch in the mouse imiquimod model of psoriasiform dermatitis: sex differences and roles of TRPV1 and TRPA1. [europepmc]
• Psoriasis Prevalence in Adults in the United States. [europepmc]
• Work absenteeism and disability associated with psoriasis and psoriatic arthritis in the USA-a retrospective study of claims data from 2009 TO 2020. [europepmc]
• Thrombosis in Psoriasis: Cutaneous Cytokine Production as a Potential Driving Force of Haemostatic Dysregulation and Subsequent Cardiovascular Risk. [europepmc]
• COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses. [europepmc]
• Exploring Biologic Treatment Hesitancy Among Black and Indigenous Populations in Canada: a Review. [europepmc]
• The risk of COVID-19 in patients with psoriasis: A retrospective cohort study. [europepmc]
• Racial disparities in dermatology. [europepmc]
• Eicosapentaenoic Acid Influences the Lipid Profile of an In Vitro Psoriatic Skin Model Produced with T Cells. [europepmc]
• Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis. [europepmc]
• Redefining Disease Severity with Special Area Involvement and Reflecting on Treatment Patterns in a Real-World Psoriasis Population. [europepmc]
• Psoriasis in People With Skin of Color: An Evidence-Based Update. [europepmc]